Home/Filings/4/0001062993-22-002733
4//SEC Filing

KISHORE GANESH 4

Accession 0001062993-22-002733

CIK 0001822691other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 7:33 PM ET

Size

7.1 KB

Accession

0001062993-22-002733

Insider Transaction Report

Form 4
Period: 2022-02-02
Transactions
  • Award

    Common Stock

    2022-02-02+5,743,5755,743,575 total(indirect: by MLS Capital Fund II, L.P.)
  • Purchase

    Common Stock

    2022-02-02$10.00/sh+75,000$750,0005,818,575 total(indirect: by MLS Capital Fund II, L.P.)
Footnotes (3)
  • [F1]Issued pursuant to the terms of a business combination agreement involving the issuer and GreenLight Biosciences, Inc. in exchange for capital stock previously issued by such company.
  • [F2]Mr. Kishore, a director of the Issuer, is the Manager of MLS Capital fund II, L.P. and has the power to vote, or to direct the voting of, the shares held by MLS Capital fund II, L.P. By virtue of the foregoing, Mr. Kishore may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the shares held by MLS Capital fund II, L.P. Mr. Kishore disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.
  • [F3]Amount consists of 75,000 shares of common stock issued pursuant to a subscription agreement entered into between the Issuer and MLS Capital fund II, L.P.

Issuer

GreenLight Biosciences Holdings, PBC

CIK 0001822691

Entity typeother

Related Parties

1
  • filerCIK 0001083218

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 7:33 PM ET
Size
7.1 KB